Where is AI VIVO located?

AI VIVO is headquartered in Cambridge, United Kingdom.

Who is the current CEO of AI VIVO?

Peyman Gifani of AI VIVO. They have also founded 1 company.

Which legal entities is AI VIVO associated with?

AI VIVO is associated with AIVIVO LTD.

How many employees does AI VIVO have?

As of Mar 31, 2025, the latest employee count at AI VIVO is 3.

Is AI VIVO a funded company?

AI VIVO is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does AI VIVO rank among its competitors?

AI VIVO ranks 5th amongst 53 active competitors, of which 6 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was PLAI Labs, which secured $32M in Jan, 2023.

Who are the top competitors of AI VIVO?

AI VIVO's top competitors include Benchling, Seqera Labs and PubHive. Among them, PLAI Labs secured the most recent funding round in January, 2023.

AI VIVO - 2026 Company Profile, Team, Funding, Competitors & Financials

AI VIVO is a funded company based in Cambridge (United Kingdom), founded in 2017 by Peyman Gifani. It operates as an AI enabled platform for data analytics and drug development. The company has 53 active competitors, including 6 funded and 4 that have exited. Its top competitors include companies like Benchling, Seqera Labs and PubHive.

Company Details

AIVIVO offers an AI-powered platform for data analytics and drug development. The platform analyses novel biological hypothesis formulations using an optimized prediction engine for data generation, representation, pipeline generation, provide actionable medical insights for drug discoveries and experimental validation.

Website: aivivo.co
Email ID: *****@aivivo.co

Key Metrics

Founded Year

2017

Location

Cambridge, United Kingdom

Stage

Funding Raised

Investors

Martlet Capital & 1 more

Ranked

5^th among 53 active competitors

Employee Count

3 as on Mar 31, 2025

Similar Companies

OpenEvidence & 2410 more

View AI VIVO's full profile

AI VIVO is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
AIVIVO LTD CIN: 10694447 , United Kingdom, Active	Mar 27, 2017	-	3 (As on Mar 31, 2025)

AI VIVO is a funded company. AI VIVO has 2 institutional investors.

View details of AI VIVO's funding rounds and investors

The founders of AI VIVO is Peyman Gifani. Peyman Gifani is the CEO of AI VIVO.

Here are the details of AI VIVO's key team members:

Peyman Gifani: Founder & CEO of AI VIVO.

View details of AI VIVO's Founder profiles and Board Members

AI VIVO's employee count trend

AI VIVO has 3 employees as of Mar 25. The total employee count is 50.0% more than what it was in Mar 24. Here is AI VIVO's employee count trend over the years:

Uncover AI VIVO's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AI VIVO include Benchling, Seqera Labs and PubHive. Here is the list of Top 10 competitors of AI VIVO, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Draper & 28 others	73/100
2nd	Seqera Labs 2018, Barcelona (Spain), Series A	Provider of a bioinformatics platform for scientific data analysis and workflow management	$27.2M	Addition Capital, Speedinvest & 6 others	44/100
3rd	PubHive 2020, London (United Kingdom), Unfunded	Provider of a cloud-based solution for scientific literature workflow management	-	-	41/100
4th	Curoverse 2010, Boston (United States), Acquired	Biomedical data solutions empowering precision medicine through open source technology	$1.7M	Converge, PJC & 6 others	41/100
5th	AI VIVO 2017, Cambridge (United Kingdom), Funding Raised	AI enabled platform for data analytics and drug development	-	Martlet Capital, o2h ventures	39/100
6th	Infonetica 2003, Esher (United Kingdom), Acquired	Provider of software solution for clinical research	-	JB46, Milk Street Ventures & 2 others	36/100
7th	Linum Labs 2016, Cape Town (South Africa), Unfunded	Blockchain-based solutions for multi-industry applications	-	-	33/100
8th	FlaskAI 2024, Bengaluru (India), Unfunded	AI-powered knowledge management platform	-	-	32/100
9th	PLAI Labs 2023, Culver City (United States), Seed	Provider of infrastructure for deploying governed and auditable artificial intelligence	$32M	Andreessen Horowitz, Crush Ventures	32/100
10th	Vyasa 2016, Newburyport (United States), Acquired	Provider of deep learning platform for life sciences market research	-	MassDevelopment, MassChallenge	32/100